{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:44:05Z","timestamp":1786358645566,"version":"build-2736575974"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,7,23]]},"abstract":"Importance<\/jats:title>In 2016, our institution adopted a pregnancy-related venous thromboembolism (VTE) prophylaxis protocol based on American College of Obstetricians and Gynecologists guidelines that recommended postpartum heparin-based chemoprophylaxis (enoxaparin) based on a risk-stratified algorithm. In response to increased wound hematomas without significant reduction in VTE using this protocol, a more selective risk-stratified approach was adopted in 2021.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate outcomes of the more selective risk-stratified approach to heparin-based obstetric thromboprophylaxis (enoxaparin) protocol.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>Retrospective observational study of 17\u202f489 patients who delivered at a single tertiary care center in the southeast US between January 1, 2016, and December 31, 2018 (original protocol), and between December 1, 2021, and May 31, 2023 (more selective protocol). Patients receiving outpatient anticoagulation for active VTE or high VTE risk during pregnancy were excluded.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Standard risk-stratified and more selective postpartum VTE chemoprophylaxis protocols.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was clinical diagnosis of wound hematoma up to 6 weeks pos tpartum. The secondary outcome was new diagnosis of VTE up to 6 weeks post partum. We compared baseline characteristics and outcomes between groups and estimated adjusted odds ratios with 95% CIs of primary and secondary outcomes using the original protocol group as reference.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 17\u202f489 patients included in the analysis, 12\u202f430 (71%) were in the original protocol group and 5029 (29%) were in the more selective group. Rates of chemoprophylaxis decreased from 16% (original protocol) to 8% (more selective protocol). Patients in the more selective group were more likely to be older, be married, and have obesity or other comorbidities (hypertension, diabetes, cardiac disease). Compared with the original protocol, the more selective protocol was associated with a decrease in any wound hematoma (0.7% vs 0.3%; adjusted odds ratio [aOR], 0.38; 95% CI, 0.21-0.67), specifically due to a lower rate of superficial wound hematomas (0.6% vs 0.3%; aOR, 0.43; 95% CI, 0.24-0.75). There was no significant increase in VTE or individual types of VTE (0.1% vs 0.1%; aOR, 0.40; 95% CI, 0.12-1.36).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>A more selective risk-stratified approach to an enoxaparin thromboprophylaxis protocol for VTE was associated with decreased rates of wound hematomas without increased rates of postpartum VTE.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jama.2024.8684","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T17:54:17Z","timestamp":1719510857000},"page":"310","source":"Crossref","is-referenced-by-count":23,"title":["A More Selective vs a Standard Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol"],"prefix":"10.1001","volume":"332","author":[{"given":"Macie L.","family":"Champion","sequence":"first","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women\u2019s Reproductive Health at the University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina T.","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women\u2019s Reproductive Health at the University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Y.","family":"Lu","sequence":"additional","affiliation":[{"name":"St David\u2019s Medical Center, Austin, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Shea","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women\u2019s Reproductive Health at the University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna I.","family":"Lively","sequence":"additional","affiliation":[{"name":"Marnix E. Heersink School of Medicine, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Morgan","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Marnix E. Heersink School of Medicine, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha E.","family":"Howell","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women\u2019s Reproductive Health at the University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women\u2019s Reproductive Health at the University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Casey","sequence":"additional","affiliation":[{"name":"West Virginia University, Department of Obstetrics, Gynecology, and Reproductive Sciences; Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N.","family":"Battarbee","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women\u2019s Reproductive Health at the University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akila","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women\u2019s Reproductive Health at the University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"joi240064r1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1182\/asheducation-2014.1.387","article-title":"Pregnancy and venous thromboembolism: \u2018TIPPS\u2019 for risk stratification.","volume":"2014","author":"Rodger","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"joi240064r2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ajog.2020.09.033","article-title":"Society for Maternal-Fetal Medicine Consult Series #51: thromboembolism prophylaxis for cesarean delivery.","volume":"224","author":"Friedman","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"joi240064r3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"ACOG Practice Bulletin No. 196: thromboembolism in pregnancy.","volume":"132","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"10","key":"joi240064r4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study.","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"issue":"4","key":"joi240064r5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study.","volume":"6","author":"Pomp","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"2","key":"joi240064r6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011-2013.","volume":"130","author":"Creanga","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"5","key":"joi240064r8","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality.","volume":"194","author":"James","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"joi240064r11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1067\/mob.2001.107919","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study.","volume":"184","author":"Danilenko-Dixon","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"joi240064r12","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1067\/mob.2000.105405","article-title":"The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes.","volume":"182","author":"Kovacevich","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"joi240064r13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.chest.2016.05.021","article-title":"Risks of venous thromboembolism after cesarean sections: a meta-analysis.","volume":"150","author":"Blondon","year":"2016","journal-title":"Chest"},{"issue":"4","key":"joi240064r14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/00006250-199910000-00021","article-title":"Thrombotic risk during pregnancy: a population study.","volume":"94","author":"Lindqvist","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"2","key":"joi240064r15","doi-asserted-by":"publisher","first-page":"233.e1","DOI":"10.1016\/j.ajog.2007.08.041","article-title":"Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium\u2014a register-based case-control study.","volume":"198","author":"Jacobsen","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"joi240064r16","doi-asserted-by":"publisher","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"4","key":"joi240064r17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.thromres.2006.12.003","article-title":"Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study.","volume":"120","author":"Larsen","year":"2007","journal-title":"Thromb Res"},{"issue":"2","key":"joi240064r19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/j.semperi.2015.11.012","article-title":"Venous thromboembolism bundle: risk assessment and prophylaxis for obstetric patients.","volume":"40","author":"Friedman","year":"2016","journal-title":"Semin Perinatol"},{"issue":"4","key":"joi240064r20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/AOG.0000000000004521","article-title":"Evaluation of a risk-stratified, heparin-based, obstetric thromboprophylaxis protocol.","volume":"138","author":"Lu","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"2","key":"joi240064r21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0002-9378(78)90373-3","article-title":"Classification of obstetric diabetes.","volume":"130","author":"White","year":"1978","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"joi240064r22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/AOG.0000000000005037","article-title":"Adjunctive azithromycin prophylaxis for prelabor cesarean birth.","volume":"141","author":"Ruzic","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"1","key":"joi240064r23","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1097\/AOG.0000000000002703","article-title":"ACOG Practice Bulletin No. 197: inherited thrombophilias in pregnancy.","volume":"132","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"joi240064r24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/AOG.0b013e3182029180","article-title":"Rate of wound complications with enoxaparin use among women at high risk for postpartum thrombosis.","volume":"117","author":"Ferres","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"9","key":"joi240064r25","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/bjo.2018.125.issue-9","article-title":"Postpartum venous thromboembolism prophylaxis may cause more harm than benefit: a critical analysis of international guidelines through an evidence-based lens.","volume":"125","author":"Kotaska","year":"2018","journal-title":"BJOG"},{"key":"joi240064r9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/B978-0-323-32108-2.00003-2","volume-title":"Gabbe\u2019s Obstetrics Essentials: Normal and Problem Pregnancies","author":"Antony","year":"2017"},{"key":"joi240064r10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/B978-0-323-32108-2.00038-X","volume-title":"Gabbe\u2019s Obstetrics Essentials: Normal and Problem Pregnancies","author":"Whitty","year":"2017"},{"key":"joi240064r7","unstructured":"Centers for Disease Control and Prevention. Pregnancy Mortality Surveillance System. Updated February 6, 2023. Accessed May 29, 2024. https:\/\/www.cdc.gov\/maternal-mortality\/php\/pregnancy-mortality-surveillance\/index.html"},{"key":"joi240064r18","unstructured":"Royal College of Obstetricians and Gynaecologists. Reducing the Risk of Venous Thromboembolism During Pregnancy and the Puerperium: Green Top Guideline No. 37a. Published April 2015. Accessed May 29, 2024. https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/reducing-the-risk-of-thrombosis-and-embolism-during-pregnancy-and-the-puerperium-green-top-guideline-no-37a\/"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2820391\/jama_champion_2024_oi_240064_1721328826.25464.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T17:36:57Z","timestamp":1721756217000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2820391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7,23]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.8684","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,23]]}}}